Table 4.

Surfactant Treatment in the GBS Group (n = 118)

Median (25th–75th percentiles)
age at treatment (h)
6 (3–12)
Mean (± SD) initial dose (mg/kg)142 ± 53
Mean (± SD) total dose (mg/kg)215 ± 116
Number of surfactant doses (n[%])
156 (48)
233 (28)
324 (20)
>35 (4)
Surfactant used (n [%])
Alveofact (Dr Karl Thomae GmbH,
Biberach, Germany)
12 (10)
Curosurf (Chiesi Farmaceutici,
Parma, Italy)
90 (76)
Exosurf (Wellcome GmbH)3 (3)
Survanta (Abboth GmbH, Wiesbaden,
Germany)
13 (11)
  • SD indicates standard deviation.